Posted on

Article: H.C. Wainwright Maintains a Buy Rating on BerGenBio AS (BRRGF)

Article - Media

H.C. Wainwright Maintains a Buy Rating on BerGenBio AS (BRRGF)

Christine Brown

SmarterAnalyst, 29 April 2020

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on BerGenBio AS (BRRGF) today and set a price target of NOK66.00. The company’s shares closed last Monday at $1.23.

According to TipRanks.com, Pantginis is a 5-star analyst with an average return of 8.2% and a 41.6% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Lineage Cell Therapeutics, and Iovance Biotherapeutics.

Read full article.

 

Comment: This company is at risk of collusion between a placement agent and naked short sellers.

RELATED:
Posted on

Article: Wirecard – what KPMG’s report found

Article - Media

Wirecard: what KPMG’s report found

The payments group had predicted vindication from a special audit — it did not arrive

Dan McCrum and Olaf Storbeck

Financial Times, 29 April 2020

For months Wirecard had confidently predicted that KPMG would vindicate its accounting and deliver a final riposte to its sceptics. Instead, the publication on Tuesday of a report from the accounting firm caused shares in the Dax 30 company to crash 26 per cent as investors learnt that KPMG’s investigators had faced obstacles in their attempts to verify that large parts of the business were real, and publication of full-year results would be delayed again. The shares fell another 7 per cent on Wednesday.

Paywall Access to Full Article.

Posted on

Article: 21.2 Million Reasons Aurora Cannabis Is a Terrible Stock

Article - Media, Publications

21.2 Million Reasons Aurora Cannabis Is a Terrible Stock

Sean Williams, 28 April 2020

If you thought the stock market has been taken on a wild ride over the past two months, then take a closer look at how marijuana stocks have fared since the beginning of April 2019. Following the first quarter of 2019, which saw numerous pot stocks rocket into the stratosphere, the past 13 months have erased anywhere from 50% to 95% of cannabis stock valuations.

Mind you, the long-term outlook for the legal weed industry is promising. Tens of billions of dollars in sales are conducted in the black market each year, meaning there’s a very real opportunity to move these illicit users to legal channels over time. But in the short run, U.S. pot stocks have been crushed by high tax rates, while Canadian cannabis companies have run into supply bottlenecks and shortages, depending on the province.
Continue reading “Article: 21.2 Million Reasons Aurora Cannabis Is a Terrible Stock”

Posted on

Academic: Robert J. Shapiro

Academic

Robert J. Shapiro (born 1953) is the cofounder and chairman of Sonecon, LLC, a United States private consultancy for economic and security-related issues that has built a reputation on a range of policy matters, including climate change, intellectual property, securities fraud, healthcare reform, demographics, the resilience of the electric grid to cyberattacks, and blockchain technologies.

Beyond Dr. Shapiro’s responsibilities and leadership at Sonecon, he is also currently a Senior Fellow of the McDonough School of Business at Georgetown University, a board member of the Medici Venture Fund, and a member of the advisory boards of Gilead Sciences and Cote Capital.

Continue reading “Academic: Robert J. Shapiro”

Posted on

Release: ALERT FROM FIRM THAT FILED THE LAWSUIT The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fifth Third Bancorp and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Release

ALERT FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fifth Third Bancorp and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

27 April 2020

Investors who purchased the Company’s securities between February 26, 2016 and March 6, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before June 8, 2020.

Read full release.

Posted on

Release: RM LAW Announces Class Action Lawsuit Against Bed Bath & Beyond Inc.

Release

RM LAW Announces Class Action Lawsuit Against Bed Bath & Beyond Inc.

27 April 2020

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Bed Bath & Beyond, Inc. (“Bed Bath & Beyond” or the “Company”) (NASDAQ: BBBY) securities during the period from October 2, 2019 through February 11, 2020, inclusive (the “Class Period”).

Read full release.

Posted on

Article: Against the short-selling ban

Article - Media

Against the short-selling ban

Jamie Powell

Financial Times, 18 March 2020

In the past seven days, various bans on short-selling — the practice of betting on a stock falling in price — have come into effect across Italy, France, Belgium, Spain and Greece. The reason? In Italian regulator Consob’s own words: “these measures were made necessary by the strong turbulences triggered in the last days by the Covid-19 pandemic”.

Continue reading “Article: Against the short-selling ban”

Posted on

Release: Andrew Left Naked Short Selling Inovio? Block & Leviton in Collusion Defaming and Committing Tortious Interference?

Release

Citron Research Further Criticizes Inovio Pharmaceuticals, Inc.; Investors Who Lost Money Should Contact Block & Leviton LLP Who Filed First Shareholder Lawsuit

Global Newswire, 27 April 2020

BOSTON, April 27, 2020 (GLOBE NEWSWIRE) — Today, research analyst Citron Research published a report calling Inovio (INO) “The COVID-19 Version of Theranos,” in which Citron slashed its target price for Inovio common stock by 93%.

Dr Left has a $1 target stock is $11 ( you know he shorted at $16-17 and covered already never waiting for his $1 target   SHORT AND DISTORT  for a quick profit

Continue reading “Release: Andrew Left Naked Short Selling Inovio? Block & Leviton in Collusion Defaming and Committing Tortious Interference?”

Posted on

Article: Market manipulation persists in London’s financial district

Article - Media, Publications

Market manipulation persists in London’s financial district

LLB EDITOR, 27 April 2020

A total of 822 reports of suspected market manipulation were made to the FCA last year (year end Dec 31 2019) by market participants, suggesting that the problem is far from being eradicated, says RPC, the City-headquartered law firm.

The number of reports of market manipulation saw a slight increase last year, rising from 812 in 2018.

Market manipulation is the attempt to artificially increase or decrease the price of an asset, index or its derivative in order to make a gain. Following the LIBOR scandal that broke in 2012, the laws relating to market manipulation were significantly tightened up. This included criminalising the attempted manipulation of benchmarks (Financial Services Act 2012). Continue reading “Article: Market manipulation persists in London’s financial district”

Posted on

Data: FINRA Daily Text Files of Short Sales

Data

April 2020 Reg SHO Daily Files

Pursuant to a Securities and Exchange Commission request, FINRA has agreed to make reported short sale trade data publicly available. Daily Short Sale Volume File formatting guide. Please note that in rare instances, files may be updated on the next business day. Original files will be retained and updated files will be identified as “Updated”.

Web Page for Online TXT Files

Posted on

Data: BuyIns.net — Naked Short List, Trigger Alerts & Reports

Data

Regulation SHO took effect January 3, 2005, and provides a new regulatory framework governing short selling of securities. It was designed with the objective of simplifying and modernizing short sale regulation and providing controls where they are most needed. At the conclusion of each settlement day, data is provided on securities in which: 1) there are at least 10,000 shares in aggregate failed deliveries for the security for five consecutive settlement days, and 2) these failures constitute at least 0.5% of the issuer’s total shares outstanding. SEC Regulation SHO, under the Securities Exchange Act of 1934, mandates that, if a clearing agent has had a fail-to-deliver position for 13 consecutive settlement days, that clearing agent, and the broker/dealer it clears for, must purchase securities to close out its fail to deliver position.

BUYINS.NET has automated the collection of this data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS every night and uses counters to track which stocks are about to have forced covers.

Home Web Page

Posted on

Article: Tesla short-sellers take record losses in battle with Elon Musk

Article - Media

Tesla short-sellers take record losses in battle with Elon Musk

Richard Henderson

Irish Times, 3 February 2020

Investors betting against Tesla suffered record losses of $5.8 billion (€5.2 billion) in January after the stock hit a new high, marking a win for chief executive Elon Musk in a long-running battle with short-sellers.

Mr Musk’s testy sparring online with notable short-sellers, including David Einhorn of Greenlight Capital, has become one of the fiercest rivalries in capital markets.

Read full article.